Tan Yu Guang
Skip Ribbon Commands
Skip to main content
Menu
Dr Tan Yu Guang

Dr Tan Yu Guang

Associate Consultant

Specialty: Urology

Clinical Appointments

  • Associate Consultant Urology Singapore General HospitalSingapore General Hospital

Profile

​Dr Tan Yu Guang is an Associate Consultant with the Department of Urology, Singapore General Hospital. He manages general urological conditions with a subspecialty interest in uro-oncology and minimally invasive surgery.


Dr Tan completed his medical training at the Yong Loo Lin School of Medicine, National University of Singapore in 2014, and graduated with distinction across the medicine and surgery tracks. He commenced his urology residency the following year, making him amongst the youngest trainee. During his training, he was awarded the Outstanding Resident Award on multiple occasions, and underwent the National Chief Resident Program of which he was recognized with the Outstanding Chief Resident Award. He completed his residency in 2023, where he was conferred the Gold Medalist for his top performance at the exit examination. 

Dr Tan is a keen academic researcher, and he believes into incorporating evidence-based medicine to provide the best care for his patients. His main research interests include prostate and bladder cancers. He has published over 30 peer-reviewed manuscripts, many of which he was the first author. He has won numerous international prizes for his research works, and was an invited speaker for regional conferences. He also completed a Masters in Clinical Investigation (MCI) during residency to complement his research pursuits. 

Dr Tan believes in providing the best care for his patients. He is detailed and compassionate, and builds a strong relationship with all his patients. He has received several commendations for his clinical service. 

Education

  • FAMS (Urol) 2023
  • MCI (NUS) 2022
  • DWD CAW 2017
  • MRCS (Edin) 2016
  • MBBS (NUS) 2014

Professional Appointments and Committee Memberships

  • Duke-NUS Adjunct Research Fellow 2022
  • Singhealth Associate in Education 2021

Awards

Research Interests

Publications

  1. ​DWJ Ng, CS Chia, GHC Tan, YG Tan, MCC Teo. A case of portomesenteric venous gas found with extensive secondary pneumatosis intestinalis in the small bowel, stomach and distal oesophagus on radiographic images with an insidious presentation. Clinical J Gastroenterology, 2014 Apr; 7: 140-3, https://doi.org/10.1007/s12328-014-0464-8
  2. M Ong, YG Tan, KY Tan. Impact of surgical delay on outcomes in elderly patients undergoing emergency surgery: A single centre experience. World Journal of Gastrointestinal Surgery, 2015 Sep; 7: 208-13, doi: 10.420/wjgs.v7.i9.208
  3. YG Tan, CS Chia, WL Loh, MCC Teo. Single-institution review of managing Dermatofibrosarcoma Protuberans. ANZ Journal of Surgery, 2016 May; 86: 372-6, doi: 10.1111/ans.13276
  4. YG Tan, G Tan, D Tan, CS Chia, DY Ang, MCC Teo. Urological Reconstruction after Pelvic Oncological Surgery. Asian Journal of Surgery, 2017 Sep; 40: 389-95, doi: 10.1016/j.asjsur.2016.02.002
  5. YG Tan, WKO Lau, HH Huang, TWK Tan. Prostate-specific antigen bounce after intensity-modulated radiation therapy in an Asian population. Asian Journal of Urology, 2017 Apr; 3: 59-63, doi: 10.1016/j.ajur,2015.12.001
  6. YG Tan, E Eu, HH Huang, WKO Lau. Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumour staging in patients undergoing radical cystectomy for bladder cancer. Asian Journal of Urology, 2017 Oct; 4: 239-46, doi: 10.1016/j.ajur.2017.01.004
  7. YG Tan, E Eu, HH Huang, WKO Lau. High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced / metastatic urothelial bladder cancer. International Journal of Urology, 2018 Mar; 25: 232-38, doi: 10.1111/iju.13480
  8. K Chen, E Eu, YG Tan, H Ho, ASP Sim, C Schwentner. Video – Zero-Ischemia Laparoscopic Partial Nephrectomy with Hydrodissection: Technique and Early Experience from a Multicenter Study. Journal of Endourology – Videourology; 2018 Feb, Vol 32 No.1. https://doi.org/10.1089/vid/2017.0027
  9. YG Tan, K Chen, D Tan, G Pek, HH Huang, ASP Sim. Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. Investigative and Clinical Urology, 2018 Jul; 59: 238-45, doi: 10.4111/icu.2018.59.4.238
  10. YG Tan, J Sia, HH Huang, WKO Lau. Neutrophil-to-lymphocyte ratio independently predicts advanced pathological staging and poorer survival outcomes in testicular cancer. Investigative and Clinical Urology, 2019 Apr; 60: 176-83, doi: 10.4111/icu.2019.60.3.176
  11. YG Tan, SH Neo, K Chen, GC Teh, C Schwentner, ASP Sim. Key surgical techniques in radical nephrectomy and IVC thrombectomy in advanced renal cell carcinoma. Urology Video Journal, 2019 Jun, 100008, https://doi.org/10.1016/u.urolvj.2019.100008
  12. YG Tan, NK Laskmi, TL Yap, N Sadhana, CCP Ong. Preventing the O in OHVIRA (Obstructed Hemivagina Ipsilateral Renal Agenesis): Early Diagnosis and Management of Asymptomatic Herlyn-Werner-Wunderlich Syndrome. Journal of Paediatric Surgery, 2020 Jul;55(7): 1377-80, doi: 10.1016/j.jpedsurg.2019.06.006
  13. YG Tan, DWK Chan, FKP Yap, TL Yap. Hypertensive urgency in nephrogenic diabetes insipidus with concomitant Hinman syndrome. British Medical Journal Case Report, 2019 Jul; 12(7):e229095, doi: 10.1136/bcr-2018-229095
  14. YG Tan, TK Ng, JSP Yuen. Endoscopic-assisted transvesical laparoscopy: A new paradigm in minimally-invasive bladder surgery. Journal of Endourology – Videourology; 2020 Apr, Vol 34 No.2, https://doi.org/10.1089/vid.2019.0100
  15. YG Tan, K Chen, ASP Sim. Robotic Anatrophic Nephrolithotomy, An alternative in managing complex renal stone. Urology Video Journal, 2020 Mar; 5, https://doi.org/10.1016/j.urolvj.2020.100026
  16. YG Tan, MFB Khalid, A Villanueva, HH Huang, K Chen, ASP Sim. Are all Small Renal Masses the Same?. International Journal of Urology, 2020 May; 27(5): 439-47, doi: 10.1111/iju.14219
  17. YG Tan, L Pang, MFB Khalid, R Poon, HH Huang, K Chen, KJ Tay, WKO Lau, C Cheng, H Ho, JSP Yuen. Local and Systemic Morbidities of de novo Metastatic Prostate Cancer: Insight from 685 Consecutive Patients from a Large Prospective Uro-oncology Registry. British Medical Journal Open – 2020 Feb; 10: e034331, doi:10.1136/bmjopen-2019-034331
  18. YG Tan, R Poon, L Pang, A Villanueva, HH Huang, K Chen, TK Ng, KJ Tay, H Ho, JSP Yuen. Comparative Study of Surgical and Medical Castration in Treatment Efficacy, Adverse Effects and Cost Based on a Large Prospective Metastatic Prostate Cancer Registry. Urologic Oncology; 2020 Aug; 38: 682e1-9, https://doi.org/10.1016/j.urolonc.2020.05.005
  19. YG Tan, JC Allen, KJ Tay, HH Huang, LS Lee. The benefit of robotic cystectomy compared to open cystectomy in an Enhanced Recovery After Surgery programme – a propensity matched analysis. International Journal of Urology, 2020 Sep; 27(9): 783-88, doi.10.1111/iju.14300
  20. YG Tan, F Khalid, HH Huang, K Chen, KJ Tay, WKO Lau, CWS Cheng, NT Ngo, JSP Yuen. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry. The Prostate; 2021 Mar; 81: 242-51
  21. AWX Low, K Chen, YG Tan, TK Ng, JSP Yuen. Ambulatory robot-assisted laparoscopic radical prostatectomy with extended recovery by total extraperitoneal approach. International Journal of Urology, 2021 Jan
  22. YG Tan, Quek SZH, HH Huang, HSS Ho, JSP Yuen, KJ Tay, JKL Tuan, K Chen. Serum testosterone levels and testosterone ‘bounce’ phenomenon predict response to novel anti-androgen therapies in castration-resistant prostate cancer. Urologic Oncology; 2021 May; https://doi.org/10.1016/j.urolonc.2021.04.009
  23. YG Tan, JSP Yuen, HSS Ho, CWS Cheng, NT Ngo, YM Law, KJ Tay. Key Steps in the Evaluation and Treatment Planning for Prostate Focal Cryotherapy. Journal of Endourology – Videourology; 2021 Aug;  https://doi.org/10.1089/vid.2021.0048
  24. Isaac Seow-En, YG Tan, KJ Tay. Laparoscopic sphincter‐preserving total pelvic exenteration with transanal total mesorectal excision for locally advanced rectal cancer – a video vignette. Colorectal Disease; 2021 Dec; https://doi.org/10.1111/codi.16011
  25. Alvin Lee YM, K Chen, YG Tan, HJ Lee, CWS Cheng, Henry SS Ho, JSP Yuen, YM Law, NT Ngo, KJ Tay. Reducing the number of systemic biopsy cores in the era of targeted biopsy – implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer and Prostatic diseases; 2022 Feb; https://doi.org/10.1038/s41391-021-00485-3
  26. YG Tan, Andrew HS Fang, Jay KS Lim, F Khalid, K Chen, Henry SS Ho, JSP Yuen, HH Huang, KJ Tay. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy. The Prostate; 2022 Feb; 82: 298-305
  27. YG Tan, JSM Teo, TLC Kuo, L Guo, LM Shi, V Shutchaidat, EJ Aslim, LG Ng, HSS Ho, KT Foo. A systemic review and meta-analysis of transabdominal intravesical prostatic protrusion assessment in determining bladder outlet obstruction and unsuccessful trial without catheter. European Urology Focus; 2022 Jul; https://doi.org/10.1016/j.euf.2021.09.016
  28. R Gatsinga, YG Tan, NT Ngo, JSM Teo. Priapism mimic: penile metastasis from hepatocellular carcinoma. BMJ Case Reports; 2022 Mar; 15: e248127
  29. YG Tan, YM Law, NT Ngo, LY Khor, PH Tan, EHW Ong, JSP Yuen, HSS Ho, JKL Tuan, R Kanesvaran, RT Gupta, S Rozen, MLK Chua, TJ Polascik, KJ Tay. Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study. The Prostate; Jun 2023; 83: 781-91 https://doi.org/10.1002/pros.24517
  30. S Deivasigamani, S Kotamarti, AR Rastinehad, RS Salas, et al. Primary whole-gland ablation for the treatment of clinically localized prostate cancer: A Focal Therapy Society best practice statement. European Urology; Dec 2023; 84: 547-560
  31. XY Yang, YG Tan, R Gatsinga, et al. Far from the truth: Real-world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification. Int J Urol; Nov 2023; 30: 991-999

Research Trials